| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adding docetaxel to cisplatin and fluorouracil in patients with unresectable head and neck cancer: a cost–utility analysis
|
Liberato, N.L.
|
|
|
23 |
7 |
p. 1825-1832
|
artikel
|
| 2 |
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan–cetuximab
|
Scartozzi, M.
|
|
|
23 |
7 |
p. 1706-1712
|
artikel
|
| 3 |
An observational study of the prevalence and incidence of comorbid conditions in older women with breast cancer
|
Danese, M.D.
|
|
|
23 |
7 |
p. 1756-1765
|
artikel
|
| 4 |
Biomarker analysis in a phase III study of pemetrexed–carboplatin versus etoposide–carboplatin in chemonaive patients with extensive-stage small-cell lung cancer
|
Smit, E.F.
|
|
|
23 |
7 |
p. 1723-1729
|
artikel
|
| 5 |
Body mass index and incidence of localized and advanced prostate cancer—a dose–response meta-analysis of prospective studies
|
Discacciati, A.
|
|
|
23 |
7 |
p. 1665-1671
|
artikel
|
| 6 |
Body mass, tobacco smoking, alcohol drinking and risk of cancer of the small intestine—a pooled analysis of over 500 000 subjects in the Asia Cohort Consortium
|
Boffetta, P.
|
|
|
23 |
7 |
p. 1894-1898
|
artikel
|
| 7 |
Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trial
|
Rayson, D.
|
|
|
23 |
7 |
p. 1780-1788
|
artikel
|
| 8 |
Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4)
|
Bosetti, C.
|
|
|
23 |
7 |
p. 1880-1888
|
artikel
|
| 9 |
Editorial board
|
|
|
|
23 |
7 |
p. ii-iii
|
artikel
|
| 10 |
Epidemiology, management and economic impact of febrile neutropenia in oncology patients receiving routine care at a regional UK cancer centre
|
Schelenz, S.
|
|
|
23 |
7 |
p. 1889-1893
|
artikel
|
| 11 |
Evaluation of glomerular filtration rate estimation by Cockcroft–Gault, Jelliffe, Wright and Modification of Diet in Renal Disease (MDRD) formulae in oncology patients
|
Ainsworth, N.L.
|
|
|
23 |
7 |
p. 1845-1853
|
artikel
|
| 12 |
Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort
|
Barba, M.
|
|
|
23 |
7 |
p. 1838-1845
|
artikel
|
| 13 |
Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial
|
Behringer, K.
|
|
|
23 |
7 |
p. 1818-1825
|
artikel
|
| 14 |
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer–subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306
|
Stintzing, S.
|
|
|
23 |
7 |
p. 1693-1699
|
artikel
|
| 15 |
Glutathione S-transferase P1 c.313A > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patients
|
Romero, A.
|
|
|
23 |
7 |
p. 1750-1756
|
artikel
|
| 16 |
Hepatitis B virus infection adds lymphoma burden in Korea
|
Huh, J.
|
|
|
23 |
7 |
p. 1926
|
artikel
|
| 17 |
High-quality care for all children with cancer
|
Knops, R.R.G
|
|
|
23 |
7 |
p. 1906-1911
|
artikel
|
| 18 |
Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors
|
Blay, J.-Y.
|
|
|
23 |
7 |
p. 1659-1665
|
artikel
|
| 19 |
Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinoma
|
Hofman, P.
|
|
|
23 |
7 |
p. 1738-1743
|
artikel
|
| 20 |
Impact of a cancer clinical trials web site on discussions about trial participation: a cluster randomized trial
|
Dear, R.F.
|
|
|
23 |
7 |
p. 1912-1918
|
artikel
|
| 21 |
IMPAKT Breast Cancer Conference
|
|
|
|
23 |
7 |
p. 1929
|
artikel
|
| 22 |
Implications of the new histological classification (WHO 2010) for pancreatic neuroendocrine neoplasms
|
Crippa, S.
|
|
|
23 |
7 |
p. 1928
|
artikel
|
| 23 |
Liquid biopsy to test new treatment strategies in breast cancer: are we there yet?
|
Ignatiadis, M.
|
|
|
23 |
7 |
p. 1653-1655
|
artikel
|
| 24 |
Long-term follow-up of high-dose chemotherapy with autologous stem-cell transplantation and response-adapted whole-brain radiotherapy for newly diagnosed primary CNS lymphoma: results of the multicenter Ostdeutsche Studiengruppe Hämatologie und Onkologie OSHO-53 phase II study
|
Kiefer, T.
|
|
|
23 |
7 |
p. 1809-1812
|
artikel
|
| 25 |
Lung malignancies after Hodgkin lymphoma: disease characteristics, detection methods and clinical outcome
|
Schoenfeld, J.D.
|
|
|
23 |
7 |
p. 1813-1818
|
artikel
|
| 26 |
Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer
|
He, X.
|
|
|
23 |
7 |
p. 1771-1780
|
artikel
|
| 27 |
Nutrient-based dietary patterns and the risk of head and neck cancer: a pooled analysis in the International Head and Neck Cancer Epidemiology consortium
|
Edefonti, V.
|
|
|
23 |
7 |
p. 1869-1880
|
artikel
|
| 28 |
Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib
|
Reichardt, P.
|
|
|
23 |
7 |
p. 1680-1687
|
artikel
|
| 29 |
Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and survival (Pantar study)
|
Aranda, E.
|
|
|
23 |
7 |
p. 1919-1925
|
artikel
|
| 30 |
Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation
|
Bondong, S.
|
|
|
23 |
7 |
p. 1795-1802
|
artikel
|
| 31 |
Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer
|
Sonpavde, G.
|
|
|
23 |
7 |
p. 1803-1808
|
artikel
|
| 32 |
Relationship between LAPTM4B gene polymorphism and susceptibility of primary liver cancer
|
Wang, S.
|
|
|
23 |
7 |
p. 1864-1869
|
artikel
|
| 33 |
Reply to the letter to the editor on hepatitis B virus infection adds lymphoma burden in Korea
|
Shin, Aesun
|
|
|
23 |
7 |
p. 1926-1927
|
artikel
|
| 34 |
Risk of venous and arterial thromboembolic events associated with anti-EGFR agents: a meta-analysis of randomized clinical trials
|
Petrelli, F.
|
|
|
23 |
7 |
p. 1672-1679
|
artikel
|
| 35 |
153Samarium-EDTMP administration followed by hematopoietic stem cell support for bone metastases in osteosarcoma patients
|
Berger, M.
|
|
|
23 |
7 |
p. 1899-1905
|
artikel
|
| 36 |
Serial FDG–PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy
|
Hendlisz, A.
|
|
|
23 |
7 |
p. 1687-1693
|
artikel
|
| 37 |
Survival in cancer of unknown primary site: population-based analysis by site and histology
|
Hemminki, K.
|
|
|
23 |
7 |
p. 1854-1863
|
artikel
|
| 38 |
Table of Contents
|
|
|
|
23 |
7 |
p. iv-vi
|
artikel
|
| 39 |
The prognostic and predictive value of serum CA19.9 in pancreatic cancer
|
Humphris, J.L.
|
|
|
23 |
7 |
p. 1713-1722
|
artikel
|
| 40 |
The validation of matrix metalloproteinase-9 mRNA gene expression as a predictor of outcome in patients with metastatic gastric cancer
|
Al-Batran, S.-E.
|
|
|
23 |
7 |
p. 1699-1705
|
artikel
|
| 41 |
Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study
|
Georgoulias, V.
|
|
|
23 |
7 |
p. 1744-1750
|
artikel
|
| 42 |
Trastuzumab induces antibody-dependent cell-mediated cytotoxicity (ADCC) in HER-2-non-amplified breast cancer cell lines
|
Collins, D.M.
|
|
|
23 |
7 |
p. 1788-1795
|
artikel
|
| 43 |
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study
|
Granata, R.
|
|
|
23 |
7 |
p. 1832-1837
|
artikel
|
| 44 |
Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial from the Hoosier Oncology Group (HOG) and US Oncology
|
Jalal, S.I.
|
|
|
23 |
7 |
p. 1730-1738
|
artikel
|
| 45 |
Validation of a predictive model that identifies patients at high risk of developing febrile neutropaenia following chemotherapy for breast cancer
|
Jenkins, P.
|
|
|
23 |
7 |
p. 1766-1771
|
artikel
|
| 46 |
X-ACT: An important step on an unfinished journey
|
Maughan, T.
|
|
|
23 |
7 |
p. 1655-1658
|
artikel
|
Tijdschrift beschrijving